{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:34:49Z","timestamp":1791196489079,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T00:00:00Z","timestamp":1422835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"MINECO","doi-asserted-by":"publisher","award":["SAF2009-08695"],"award-info":[{"award-number":["SAF2009-08695"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IDIVAL","award":["SAF2012-34203"],"award-info":[{"award-number":["SAF2012-34203"]}]},{"name":"IDIVAL","award":["AIP2014\/SAF2012-34203"],"award-info":[{"award-number":["AIP2014\/SAF2012-34203"]}]},{"name":"IDIVAL","award":["CTQ 2011-27268"],"award-info":[{"award-number":["CTQ 2011-27268"]}]},{"name":"IDIVAL","award":["HHSN272200800039C"],"award-info":[{"award-number":["HHSN272200800039C"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["API2012\/03\/SAF2009-08695"],"award-info":[{"award-number":["API2012\/03\/SAF2009-08695"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.vaccine.2015.01.062","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T13:48:29Z","timestamp":1423316909000},"page":"1465-1473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax\u2122 delta inulin adjuvant induces robust T-cell protection against listeria infection"],"prefix":"10.1016","volume":"33","author":[{"given":"Estela","family":"Rodriguez-Del Rio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Calderon-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Frande-Cabanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Penad\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Petrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Alvarez-Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2015.01.062_bib0205","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nm1276","article-title":"Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity","volume":"11","author":"Brockstedt","year":"2005","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2015.01.062_bib0210","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1128\/IAI.00390-08","article-title":"Constitutive activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains","volume":"76","author":"Lauer","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0215","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4049\/jimmunol.173.1.420","article-title":"Listeria monocytogenes as a vaccine vector: virulence attenuation or existing antivector immunity does not diminish therapeutic efficiency","volume":"173","author":"Starks","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0220","doi-asserted-by":"crossref","first-page":"8668","DOI":"10.1073\/pnas.1211287110","article-title":"Nontoxic radioactive Listeriaat is a highly effective therapy against metastatic pancreatic cancer","volume":"110","author":"Quispe-Tintaya","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0225","doi-asserted-by":"crossref","first-page":"14310","DOI":"10.1074\/jbc.M112.348615","article-title":"Phagosomes induced by cytokines function as anti-Listeria vaccines: a novel role for functional compartmentalization of Stat-1 and cathepsin-D","volume":"287","author":"Carrasco-Marin","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0230","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.vaccine.2012.02.026","article-title":"Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine","volume":"30","author":"Kono","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.01.062_bib0235","doi-asserted-by":"crossref","first-page":"e35503","DOI":"10.1371\/journal.pone.0035503","article-title":"Protective immunity to Listeria monocytogenes infection mediated by recombinant Listeria innocua harboring the VGC locus","volume":"7","author":"Mohamed","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2015.01.062_bib0240","first-page":"207","article-title":"The intact structural form of LLO in endosomes cannot protect against listeriosis","volume":"2","author":"Rodriguez-Del Rio","year":"2011","journal-title":"Int J Biochem Mol Biol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0245","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/IJN.S25875","article-title":"Ether lipid vesicle-based antigens impart protection against experimental listeriosis","volume":"7","author":"Ansari","year":"2012","journal-title":"Int J Nanomed"},{"issue":"7","key":"10.1016\/j.vaccine.2015.01.062_bib0250","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.nano.2013.03.004","article-title":"Glycodendrimers as new tools in the search for effective anti-HIV DC-based immunotherapies","volume":"9","author":"Vacas-Cordoba","year":"2013","journal-title":"Nanomed: Nanotechnol, Biol Med"},{"issue":"22","key":"10.1016\/j.vaccine.2015.01.062_bib0255","first-page":"1","article-title":"Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH","volume":"4","author":"Calderon-Gonzalez","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0260","doi-asserted-by":"crossref","first-page":"764542","DOI":"10.1155\/2010\/764542","article-title":"Induction of specific CD8 T cells against intracellular bacteria by CD8 T cell-oriented immunization approaches","volume":"2010","author":"Nagata","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"8","key":"10.1016\/j.vaccine.2015.01.062_bib0265","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.4049\/jimmunol.1300910","article-title":"Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-\u03b3 receptor subunit 1 (IFNGR1)","volume":"191","author":"Lee","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0270","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nri1461","article-title":"Immune responses to Listeria monocytogenes","volume":"4","author":"Pamer","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0275","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.4049\/jimmunol.166.3.1877","article-title":"A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8T cell epitopes from Listeria monocytogenes","volume":"166","author":"Geginat","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0280","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.4049\/jimmunol.168.4.1854","article-title":"Efficient in vivo presentation of Listeria monocytogenes derived CD4 and CD8 cell epitopes in the absence of IFN-\u03b3","volume":"168","author":"Skoberne","year":"2002","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2015.01.062_bib0285","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1128\/IAI.70.7.3592-3601.2002","article-title":"Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA\/plcB in adult volunteers: a dose escalation study of oral inoculation","volume":"70","author":"Angelakopoulos","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0290","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1016\/j.biomaterials.2010.07.093","article-title":"Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer","volume":"31","author":"Pion","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0295","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4049\/jimmunol.1302030","article-title":"Nanoparticle adjuvant sensing by TLR7 enhances CD8+ T cell-mediated protection from Listeria monocytogenes infection","volume":"192","author":"Lebel","year":"2014","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2015.01.062_bib0300","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/1521-3773(20010618)40:12<2257::AID-ANIE2257>3.0.CO;2-S","article-title":"Gold glyconanoparticles as water-soluble polyvalent models to study carbohydrate interactions","volume":"40","author":"de la Fuente","year":"2001","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0305","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bbagen.2005.12.001","article-title":"Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science","volume":"1760","author":"de la Fuente","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0310","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1039\/c2cs35420a","article-title":"Glyconanoparticles as multifunctional and multimodal carbohydrate systems","volume":"42","author":"Marradi","year":"2013","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0315","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2217\/nnm.11.151","article-title":"Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine","volume":"7","author":"Safari","year":"2012","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.062_bib0320","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1021\/cb4008265","article-title":"Galactofuranose-coated gold nanoparticles elicit a pro-inflammatory response in human monocyte-derived dendritic cells and are recognized by DC-SIGN","volume":"9","author":"Chiodo","year":"2014","journal-title":"ACS Chem Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2015.01.062_bib0325","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/glycob\/cwt053","article-title":"The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions","volume":"23","author":"Cooper","year":"2013","journal-title":"Glycobiology"},{"issue":"Aug (36)","key":"10.1016\/j.vaccine.2015.01.062_bib0330","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1016\/j.vaccine.2014.06.057","article-title":"A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax\u2122) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection","volume":"32","author":"Honda-Okubo","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0335","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/JVI.03144-12","article-title":"JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody","volume":"8","author":"Larena","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0340","doi-asserted-by":"crossref","first-page":"b10324","DOI":"10.1128\/JVI.00480-13","article-title":"An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody","volume":"18","author":"Petrovsky","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.09.034","article-title":"Immunogenicity and safety of Advax\u2122, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study","author":"Gordon","year":"2014","journal-title":"Vaccine"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2015.01.062_bib0350","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1099\/vir.0.023242-0","article-title":"Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations","volume":"92","author":"Cristillo","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0355","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1016\/j.vaccine.2012.06.009","article-title":"Randomized clinical trial of immunogenicity and safety of a recombinant H1N1\/2009 pandemic influenza vaccine containing Advax\u2122 polysaccharide adjuvant","volume":"30","author":"Gordon","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0360","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/B978-0-12-394590-7.00001-4","article-title":"Mechanisms and immunological effects of apoptosis caused by Listeria monocytogenes","volume":"113","author":"Carrero","year":"2012","journal-title":"Adv Immunol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0365","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1099\/vir.0.019190-0","article-title":"An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses","volume":"91","author":"Lobgis","year":"2010","journal-title":"J Gen Virol"},{"issue":"37","key":"10.1016\/j.vaccine.2015.01.062_bib0370","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1016\/j.vaccine.2011.06.078","article-title":"Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets","volume":"29","author":"Layton","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0375","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.vaccine.2012.06.021","article-title":"AdvaxTM, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses","volume":"30","author":"Honda-Okubo","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0380","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1002\/chem.200900923","article-title":"Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN","volume":"15","author":"Mart\u00ednez-\u00c1vila","year":"2009","journal-title":"Chem Eur J"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0385","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.carres.2006.11.018","article-title":"Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines","volume":"342","author":"Ojeda","year":"2007","journal-title":"Carbohydr Res"},{"issue":"8","key":"10.1016\/j.vaccine.2015.01.062_bib0390","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.4049\/jimmunol.1203059","article-title":"Fas-mediated inflammatory response in Listeria monocytogenes infection","volume":"190","author":"Uchiyama","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0395","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cellimm.2011.03.001","article-title":"Distint responses of splenic dendritic cell subsets to infection with Listeria monocytogenes: maturation phenotype, level of infection, and T cell priming capacity ex vivo","volume":"268","author":"Mitchell","year":"2011","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2015.01.062_bib0400","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.immuni.2011.06.012","article-title":"CD8\u03b1+ dendrititc cells are an obligate cellular entry point for productive infection of Listeria monocytogenes","volume":"35","author":"Edelson","year":"2011","journal-title":"Immunity"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T07:23:31Z","timestamp":1537860211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1500119X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0264410X1500119X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax\u2122 delta inulin adjuvant induces robust T-cell protection against listeria infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}